Table 1 Clinical characteristics of patients with SCI and NMOSD

Number of subjects

15

12

Age (years)

61.8 ± 15.3

59.5 ± 13

0.69

Female

40%

92%

0.014

Hypertension

60%

17%

0.047

Diabetes mellitus

33%

0%

0.047

Dyslipidemia

87%

17%

< 0.001

Atrial fibrillation

27%

0%

0.11

Time from symptom onset to nadir (hours)

4 [0.1–8.3]

252 [162–576]

< 0.001

Motor paresis

80%

67%

0.66

 Paraparesis

40%

42%

1

 Monoparesis

27%

17%

0.66

 Hemiparesis

7%

8%

1

 Brachial diparesis

7%

0%

1

Sensory disturbance

100%

100%

1

CSF WBC count (/µL; NR, 0–5)

1 [0–1] (9)

4.5 [3–15] (10)

0.0071

CSF total protein (mg/dL; NR, 15–50)

48 [33–53] (9)

37.5 [35.3–56.5] (10)

1

CSF/blood glucose ratio

0.56 ± 0.08 (9)

0.56 ± 0.08 (9)

0.96

Ability to walk without assistance 1 month after symptom onset

47%

50%

1